Evidence map›Paper›PMID 19996739›Full record

ReviewCurrent opinion in allergy and clinical immunology2010

Signaling pathways critical for allergic airway inflammation.

John D Colgan, Isaiah L Hankel

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in allergy and clinical immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

John D ColganDepartment of Internal Medicine, University of Iowa, Iowa City, USA. john-colgan@uiowa.edu
Isaiah L Hankel
University of Iowa · US

Funding

Regulation of Atopic Immune Responses by the Prolyl lsomerase Cyclophillin AR01AI067489 · NIAID · UNIVERSITY OF IOWA · PI COLGAN, JOHN D · 2006 to 2010
$1.8M
NIAID NIH HHS R01 AI067489NIAID NIH HHS R01AI067489
6 · The paper itself

Abstract

purpose of reviewActivated mast cells, basophils, and CD4 helper T cells have critical roles in allergic inflammation. Therefore, devising ways to specifically inhibit these cells will likely be useful for controlling allergic inflammation. We summarize recent findings regarding the role of mast cells and basophils in allergic responses and the regulation of signaling pathways downstream of the IgE receptor, the chief inducer of mast cell and basophil activation. We also highlight studies addressing the roles of the protein tyrosine kinases Zap-70 and Itk in immune system development and in the regulation of CD4 helper T cell responses. RECENT

findingsRecent work has demonstrated that mast cell function is unexpectedly diverse and that basophils have a more prominent role in Th2-type immune responses than previously appreciated. Biochemical analysis of the IgE receptor signaling pathway has led to insights regarding the roles of phosphatases and other enzymes in this process. Studies of Zap-70 and Itk have helped to define the potential outcomes and complications of inhibiting these enzymes in order to suppress allergic inflammation. SUMMARY: Analysis of genetically engineered mice and biochemical studies continue to help unravel the molecular pathways that drive allergic inflammatory reactions. The knowledge acquired may lead to novel approaches for suppressing allergic inflammation.

Indexed as

AnimalsAnimals, Genetically ModifiedBasophilsHumansHypersensitivityImmunosuppression TherapyInflammationMast CellsMiceReceptor Protein-Tyrosine KinasesReceptors, IgERespiratory SystemSignal TransductionTh2 CellsZAP-70 Protein-Tyrosine KinaseLTK protein, humanReceptor Protein-Tyrosine KinasesReceptors, IgEZAP-70 Protein-Tyrosine Kinase

Identifiers

PMID19996739
PMCPMC2838378
OpenAlexW1985936346

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.